Genisphere
Philips has been awarded
Genisphere Licenses Signal Amplification Technology to Chembio
NEW YORK (GenomeWeb News) – Genisphere said today it has licensed its 3DNA Signal Amplification technology to Chembio Diagnostics.
Quest Diagnostics has been awarded US Patent No. 8,346,485, "Methods and apparatuses for estimating initial target nucleic acid concentration in a sample by modeling background signal and cycle-dependent amplification efficiency of a polymerase chain reaction."
Genisphere and the Lankenau Institute for Medial Research said this week that they are expanding their collaboration on the development of microRNA biomarkers for ulcerative colitis to include Crohn's disease and other inflammatory bowel disorders.
Genisphere, Lankenau Institute Expand MiRNA Deal Aimed at IBD
NEW YORK (GenomeWeb News) –Genisphere and the Lankenau Institute for Medical Research today said that they have expanded their research collaboration aimed at identifying microRNA biomarkers to include Crohn's Disease and other inflammatory bowel disorders.